🇺🇸 LUTETIUM CHLORIDE LU-177 in United States

99 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 14 reports (14.14%)
  2. Anaemia — 12 reports (12.12%)
  3. Fatigue — 10 reports (10.1%)
  4. Nausea — 10 reports (10.1%)
  5. Nephropathy Toxic — 10 reports (10.1%)
  6. Pain In Extremity — 9 reports (9.09%)
  7. Thrombocytopenia — 9 reports (9.09%)
  8. Vomiting — 9 reports (9.09%)
  9. Abdominal Pain — 8 reports (8.08%)
  10. Cough — 8 reports (8.08%)

Source database →

LUTETIUM CHLORIDE LU-177 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is LUTETIUM CHLORIDE LU-177 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for LUTETIUM CHLORIDE LU-177 in United States?

Marketing authorisation holder not available in our data.